In this study, we found that bone‐metastasized HCC‐derived EVs (BM‐EVs) could localize to orthotopic HCC sites and promote HCC progression by transferring ALKBH5‐targeting miR‐3190‐5p (miR‐3190). Here, ALKBH5 is linked to hepatocellular carcinoma.